BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15358134)

  • 1. Neuroglycan C, a novel member of the neuregulin family.
    Kinugasa Y; Ishiguro H; Tokita Y; Oohira A; Ohmoto H; Higashiyama S
    Biochem Biophys Res Commun; 2004 Sep; 321(4):1045-9. PubMed ID: 15358134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and identification of a new splice variant of neuroglycan C, a transmembrane chondroitin sulfate proteoglycan, in the human brain.
    Aono S; Tokita Y; Yasuda Y; Hirano K; Yamauchi S; Shuo T; Matsui F; Keino H; Kashiwai A; Kawamura N; Shimada A; Kishikawa M; Asai M; Oohira A
    J Neurosci Res; 2006 Jan; 83(1):110-8. PubMed ID: 16299773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gamma-heregulin: a novel heregulin isoform that is an autocrine growth factor for the human breast cancer cell line, MDA-MB-175.
    Schaefer G; Fitzpatrick VD; Sliwkowski MX
    Oncogene; 1997 Sep; 15(12):1385-94. PubMed ID: 9333014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
    Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioactive recombinant neuregulin-1, -2, and -3 expressed in Escherichia coli.
    Mautino B; Dalla Costa L; Gambarotta G; Perroteau I; Fasolo A; Dati C
    Protein Expr Purif; 2004 May; 35(1):25-31. PubMed ID: 15039062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation.
    Hobbs SS; Coffing SL; Le AT; Cameron EM; Williams EE; Andrew M; Blommel EN; Hammer RP; Chang H; Riese DJ
    Oncogene; 2002 Dec; 21(55):8442-52. PubMed ID: 12466964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines.
    Wu WK; Tse TT; Sung JJ; Li ZJ; Yu L; Cho CH
    Anticancer Res; 2009 Jan; 29(1):229-34. PubMed ID: 19331154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phe45 of NRG2beta is critical for the affinity of NRG2beta for ErbB4 and for potent stimulation of ErbB4 signaling by NRG2beta*.
    Hobbs SS; Gallo RM; Riese DJ
    Growth Factors; 2005 Dec; 23(4):273-83. PubMed ID: 16338790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTAKalpha and beta isoforms stimulate breast tumor cell growth by means of different receptor combinations.
    Nakano N; Higashiyama S; Kajihara K; Endo T; Ishiguro H; Yamada K; Nagatsu T; Taniguchi N
    J Biochem; 2000 May; 127(5):925-30. PubMed ID: 10788804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel brain-derived member of the epidermal growth factor family that interacts with ErbB3 and ErbB4.
    Higashiyama S; Horikawa M; Yamada K; Ichino N; Nakano N; Nakagawa T; Miyagawa J; Matsushita N; Nagatsu T; Taniguchi N; Ishiguro H
    J Biochem; 1997 Sep; 122(3):675-80. PubMed ID: 9348101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium.
    Fuller SJ; Sivarajah K; Sugden PH
    J Mol Cell Cardiol; 2008 May; 44(5):831-54. PubMed ID: 18430438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor mutant with wild-type affinity for both ErbB1 and ErbB3.
    Wingens M; Jacobs-Oomen S; van der Woning SP; Stortelers C; van Zoelen EJ
    Biochemistry; 2006 Apr; 45(14):4703-10. PubMed ID: 16584205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the neuregulin-1/ErbB signaling pathway promotes the proliferation of neoplastic Schwann cells in human malignant peripheral nerve sheath tumors.
    Stonecypher MS; Byer SJ; Grizzle WE; Carroll SL
    Oncogene; 2005 Aug; 24(36):5589-605. PubMed ID: 15897877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB3/HER3 does not homodimerize upon neuregulin binding at the cell surface.
    Berger MB; Mendrola JM; Lemmon MA
    FEBS Lett; 2004 Jul; 569(1-3):332-6. PubMed ID: 15225657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion.
    Yokoe S; Takahashi M; Asahi M; Lee SH; Li W; Osumi D; Miyoshi E; Taniguchi N
    Cancer Res; 2007 Mar; 67(5):1935-42. PubMed ID: 17332320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
    Li Q; Ahmed S; Loeb JA
    Cancer Res; 2004 Oct; 64(19):7078-85. PubMed ID: 15466203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neural proteoglycans: neuroglycan C (NGC), neurocan, and phosphacan].
    Tokita Y; Oohira A
    Tanpakushitsu Kakusan Koso; 1997 Feb; 42(3 Suppl):567-70. PubMed ID: 9162999
    [No Abstract]   [Full Text] [Related]  

  • 19. The N-terminal domains of neuregulin 1 confer signal attenuation.
    Warren CM; Kani K; Landgraf R
    J Biol Chem; 2006 Sep; 281(37):27306-16. PubMed ID: 16825199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ErbB3 expression predicts tumor cell radiosensitization induced by Hsp90 inhibition.
    Dote H; Cerna D; Burgan WE; Camphausen K; Tofilon PJ
    Cancer Res; 2005 Aug; 65(15):6967-75. PubMed ID: 16061682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.